1McCullough AJ. Pathophysiology of nonalcoholic steatohepatitis [J]. J Clin Gastroenterol,2006,40(Suppl 1) :S17-29.
2Targher G,Bertolini L,Rodena S, et al. Non-alcoholic fatty liver disease is independently associated with an increased prevalence of chronic kidney disease and proliferative/laser-treated retinopathy in type 2 diabetic patients[J]. Diabetologia, 2008,51 (3):444-450.
3Targher G,Day CP,Bonora E. Risk of cardiovascular disease in patients with nonalcoholic fatty liver disease[J]. N Engl J Med, 2010,363 (14) : 1341-1350.
4Soderberg C, Stal P, Askling J, et al. Decreased survival of subjects with elevated liver function tests during a 28-year follow-up1[J]. Hepatology, 2010,51 (2) : 595-602.
4Armstrong MJ, Houlihan DD, Bentham L, et al. Presence and severity of non-alcoholic fatty liver disease in a large prospective primary care cohort[J]. J Hepatol, 2012,56 (1) : 234 -240.
5Singh R,Kaushik S, Wang Y, et al. Autophagy regulates lipid metabolism[J]. Nature, 2009,458(7242) : 1131-1135.
6Heaton NS, Perera R, Berger KL, et al. Dengue virus nonstructural protein 3 redistributes fatty acid synthase to sites of viral relication and increases cellular fatty acid synthesis[J]. Proc Natl Acad Sci USA, 2010,107(40) : 17345-17350.
7Le Roy T, Llopis M, Lepage P, et al. Intestinal microbiota determines development of non-alcoholic fatty liver disease in mice[J]. Gut,2013,62(12) : 1787-1794.
8Kowdley KV, Belt P, Wilson LA, et al. Serum ferritin is an independent predictor of histologie severity and advanced fibrosis in patients with nonalcoholic fatty liver disease [J]. Hepatology,2012,55 (1) :77-85.
9Rhee EJ,Kim MK,Park SE,et al. High serum vitamin D levelsreduce the risk for nonalcoholic fatty liver disease in healthy men independent of metabolic syndrome[J]. Endocr J, 2013,60 (6) ,743-752.
10Targher G, Bertolini L, Scala I., et al. Associations between serum 25-hydroxyvitamin D3 concentrations and liver histology in patients with non-alcoholic fatty liver disease [J]. Nutr Metab Cardiovasc Dis,2007,17(7):517-524.
